AMO Pharma Announces Expansion of Pivotal REACH-CDM Study in C...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
LONDON, Dec. 23, 2021 /PRNewswire-AsiaNet/ -- - Additional research centers now enrolling patients in Australia and New Zealand- Company has achieved 50 percent of target enrollment in global Phase 3 trialAMO Pharma Limited ("AMO Pharma"), a privately held biopharmaceutical co...
Authors: LATEST ASIANET NEWS RELEASES